Literature DB >> 8647868

Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells.

J C Fox1, J R Shanley.   

Abstract

Basic fibroblast growth factor (bFGF), a potent mitogen for many cell types, is expressed by vascular smooth muscle cells and plays a prominent role in the proliferative response to vascular injury. Basic FGF has also been implicated as a survival factor for a variety of quiescent or terminally differentiated cells. Autocrine mechanisms could potentially mediate both proliferation and cell survival. To probe such autocrine pathways, endogenous bFGF production was inhibited in cultured rat vascular smooth muscle cells by the expression of antisense bFGF RNA. Inhibition of endogenous bFGF production induced apoptosis in these cells independent of proliferation, and apoptosis could be prevented by exogenous bFGF but not serum or epidermal growth factor. The induction of apoptosis was associated with an inappropriate entry into S phase. These data demonstrate that interruption of autocrine bFGF signaling results in apoptosis of vascular smooth muscle cells, and that the mechanism involves disruption of normal cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647868     DOI: 10.1074/jbc.271.21.12578

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.

Authors:  D Saha; P K Datta; H Sheng; J D Morrow; M Wada; H L Moses; R D Beauchamp
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

Review 2.  Fibroblast growth factor regulation of neovascularization.

Authors:  Masahiro Murakami; Michael Simons
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

3.  Basic fibroblast growth factor regulates extracellular matrix and contractile protein expression independent of proliferation in vascular smooth muscle cells.

Authors:  S Kato; A Muraishi; T Miyamoto; J C Fox
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

Review 4.  [Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease].

Authors:  S Rosenkranz; M Böhm; A Kazlauskas
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 5.  Apoptosis in the vasculature: mechanisms and functional importance.

Authors:  Z Mallat; A Tedgui
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors.

Authors:  Yuebo Gan; M Guillaume Wientjes; Jessie L-S Au
Journal:  Pharm Res       Date:  2006-06-08       Impact factor: 4.200

7.  The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.

Authors:  Siyun Liao; Darius Porter; Alana Scott; Gilbert Newman; Thomas Doetschman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2006-12-05       Impact factor: 5.000

Review 8.  Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis.

Authors:  Y J Geng
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

9.  An A/G-rich motif in the rat fibroblast growth factor-2 gene confers enhancer activity on a heterologous promoter in neonatal rat cardiac myocytes.

Authors:  K A Detillieux; A F Meyers; J T Meij; P A Cattini
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

10.  Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2.

Authors:  Eugene G Levin; Lyudmila Sikora; Lan Ding; Savita P Rao; P Sriramarao
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.